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Purpose: Our aim is to better understand the pathomolecular mecha-
nisms involved in OA. By studying molecular components across dif-
ferent OA joints we could perhaps understand the similarities,
disparities and identify key molecular mechanisms driving OA. High-
throughput comparative proteomics approaches offer a powerful
insight into the common and different molecules and their regulatory
mechanisms present in these two different OA joints.
Methods: Human cartilage samples obtained from carpometacarpal of
the thumb (CMC-I) and knee OA were immunostained for TLRs (1-9)
and analyzed using histomorphometry and principal component
analysis (PCA). mRNA was extracted and expression levels were ana-
lyzed by RT-PCR. Synovial ﬂuid (SF) was obtained from (CMC-I) OA
(n¼10) and knee OA (n¼10) patients. SF samples were albumin
depleted and analyzed in liquid mass spectrometry (LC/MS). Selected
molecules were validated by enzyme-linked immunosorbent assay
(ELISA).
Results: Contrary to the observed homogenous TLR expression in knee
OA (p<0.05), TLRs did not display grade-dependent overall proﬁle
changes in CMC-I OA, however PCA revealed that TLR expression
proﬁles clustered accordingly to their known cellular compartmen-
talization. We observed an atypical TLR4 expression at the mRNA
(increased) and protein level (decreased) in CMC-I OA cartilage in
comparison to equivalent-graded knee OA cartilage (data not shown).
This led us to believe that perhaps relevant molecules and regulatory
mechanism are differentially regulated between the two joints. SF
analysis with speciﬁc ELISAs for soluble biglycan (BGN) and soluble
toll-like receptor (TLR4) disclosed signiﬁcant differences on the pres-
ence of these catabolic and negative regulative molecules, respectively
(Figure 1).Figure 1. Box plot representation of soluble Biglycan and TLR4 Concen-
tration levels in synovial ﬂuid obtained from arthritic patients.
Our high-throughput approach by Comparative SF proteomic analysis
revealed that 120 commonly present proteins were differentially regu-
lated in knee and CMC-I joints, with 65 proteins being over expressed by
1.3 fold difference. In additionwe identiﬁed 41 newproteinswhich have
never been reported to be present in OA synovial ﬂuid. Bioinformatic
analysis of the differential regulated proteins reveal their signiﬁcant
participation in different molecular functions (Figure 2).Figure 2. Gene ontology analysis of differentially expressed proteins in
synovialﬂuid fromCMC-I and knee OA joints. (PANTHER analysis Pathway).
Conclusions: Our results from classical immunohistochemistry and
immunoassay techniques (IHC and ELISA) combined with forefront
Proteomics techniques (LC/MS) conﬁrm the differential expression of
several keymolecular players in CMC-I and knee OA. Taken together our
study trongly suggest that pathomolecular mechanisms of OA may
differ depending on the affected joint. The reported molecules are
putative biomarkers of OA and potential therapeutic targets for OA.
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PROGRANULIN PLAYS A CHONDROPROTECTIVE ROLE IN A
SURGICALLY-INDUCED OSTEOARTHRITIS IN MICE THROUGH TNFR2
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Purpose: Progranulin (PGRN) was previously reported as an osteo-
arthritis (OA)-associated growth factor. This study aims to investigate
the role of PGRN in the pathogenesis of OA in vivo.
Methods: Progression of OA was analyzed by surgically induced OA
models in wild type, PGRN-deﬁcient, TNFR1-deﬁcient and TNFR2-
deﬁcient mice. Cartilage degradation and OA severity were evaluated
using Safranin O and HE staining, immunohistochemistry and ELISA.
Additionally, mRNA expression of degenerative factors and catabolic
markers known to be involved in cartilage degeneration in OA were
analyzed.
Results: 1. Deﬁciency of PGRN leads to exaggerated osteoarthritis pro-
gression in destabilization of the medial meniscus mice model. To
determine the role of PGRN in the course of OA progression, we used a
surgically induced OA mice model, destabilization of the medial
meniscus(DMM) mice model in both wild type and PGRN-deﬁcient
mice. Safranin O staining revealed that more severe structure loss was
presented in PGRN-deﬁcient mice than in WT mice (Fig. 1A). Osteo-
arthritis Research Society International (OARSI) scoring of OA was
performed, and demonstrated that PGRN-deﬁcient mice had a sig-
niﬁcantly higher arthritic score than theWTgroup at all the time points
(Fig.1B). COMP degradation is widely used as a biomarker for OA pro-
gression COMP fragment-speciﬁc ELISA revealed that deﬁciency of
PGRN exaggerated degradation of COMP after DMM operation
(Fig. 1C).Additionally, synovium inﬂammation and osteophyte for-
mation of WT and PGRN/mice knee joint at 4 weeks after induction
were assayed through histology (Fig.1D), PGRN-deﬁcient mice pre-
sented markedly more severe synovium inﬂammation as well as
osteophyte formation compared with WT littermates. The immuno-
histochemistry staining demonstrated stronger positive signals for Col
X, MMP13 and COMP fragments in PGRN-deﬁcient group thanwild type
group at 8 weeks after DMM operation (Fig. 1E).
2. Recombinant PGRN protects against OA in anterior cruciate ligament
transection model through the TNFR2 pathway in vivo.
To investigate whether recombinant PGRN has a protective effect
against induction and development of OA, anterior cruciate ligament
transection(ACLT) model was established in wild type, TNFR1-deﬁcient
and TNFR2-deﬁcient mice (n¼7 for each group), followed by intra-
articular injection of phosphate buffered saline (PBS) or PGRN (6 mg)
once a week for 4 weeks. As shown in Fig.2A, surgically induced OA
caused destruction of articular cartilage in all three genotypes of mice
Fig. 2. Recombinant progranulin (PGRN) attenuated osteoarthritis (OA)
development through the TNFR2 pathway in vivo. (A) Intra-articular
Injection of PGRN dramatically protected cartilage from degeneration
following surgically induced OA model, assayed by Safranin O staining.
Scale bar, 100 mm. (B) Phenotypes of synovium and osteophyte in ACLT
models at 4 weeks treated with PBS and recombinant PGRN protien (a, c)
HE staining of knee Joints samples from ACLT models treated with PBS
and recombinant PGRN protein. Black arrows indicate synovium, and blue
arrow indicates osteophyte formation in PBS treated ACLT model. (b, d)
Magniﬁed ﬁeld of synovium in PBS and PGRN treated groups. Scale bar,
100 mm, (C) Osteoarthritis Research Society International (OARSI) score of
OA, (D) The loss of Aggrecan based on the result of Safranin O staining. (E)
Treatment of PGRN reduced serum level of cartilage oligomeric matrix
protein (COMP) fragments in ACLT model, assayed by ELISA.
Fig. 1. Deﬁciency of progranulin (PGRN) led to exaggerated osteoarthritis
(OA) progression in a surgically induced model. (A) PGRN-deﬁcient mice
exhibited accelerated degeneration of articular cartilage compared with
wild type (WT) littermates, assayed by Safranin O staining. Red arrows
indicated cartilage destruction. Scale bar¼100mm. (B) PGRN deﬁcient mice
dispayed a signiﬁcantly higher score of OA after destabilisation of medial
meniscus (DMM) operation on the basis of Safranin O staining. (C) PGRN-
deﬁcient mice presented a signiﬁcantly higher level of cartilage oligo-
meric matrix protein (COMP) fragment in serum after induction of DMM
model, assayed by ELISA. (D) phenotypes of synovium and osteophyte in
DMM models established in WT and PGRN-deﬁcient mice at 4 weeks.
(a,b) HE staining of knee joints samples from DMM models established in
WT and PGRN-/- mice. Black arrows indicate osteophyte formation. (c, d)
Magniﬁed ﬁeld of osteophyte and synovium in WT and PGRN-deﬁcient
groups. Black arrows indicate osteophyte formation, and blue arrows
indicater synovium, Scale bar¼100mm. (E) immunohistochemistry stain-
ing also showed stronger positive signals for col X, matrix metal-
loproteinase (MMP)13 and COMP fragments in PGRN-deﬁcient group than
WT group 8 weeks after DMM operation. Scale bar¼50mm.
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articular injection of PGRN remarkably protected the structure of
articular cartilage and maintained proteoglycan in the cartilage. Fur-
thermore, As showed in Fig2.B, PGRN treatment dramatically attenu-
ated synovium inﬂammation observed in PBS-treated ACLTgroup ofWT
mice. Moreover, recombinant PGRN treatment exhibited a similar effect
in TNFR1-deﬁcient group, while this protective effect of PGRN was
largely lost when TNFR2 was deﬁcient. Additionally, as illustrated in
Fig.2C and 2D, histological grading analysis showed signiﬁcant
improvement of OA score and attenuation of proteoglycan loss in car-
tilage with treatment of PGRN in WT and TNFR1-deﬁcient mice, but
there was no signiﬁcant change in TNFR2-deﬁcient mice. To further
investigate OA development following treatment of PGRN, sera were
collected from each group, and COMP fragment-speciﬁc ELISA was
performed. As indicated in 2E, treatment of PGRN signiﬁcantly dimin-
ished the levels of COMP fragments in WT and TNFR1-deﬁcient ACLT
model, but not in TNFR2-deﬁcient mice. These results suggest that
PGRN-mediated protection in OA is primarily through the TNFR2
pathway.
Conclusions: PGRN protects against the progression of OA primarily
through TNFR2 signaling pathway. These in vivo studies provide new
insight into the pathogenesis of OA, and also present PGRN as a
potential target for the treatment of joint degenerative diseases,
including OA.
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Purpose: The majority of osteoarthritis (OA) patients show synovial
activation, which is suggested to be involved in joint destruction. Pre-
viously, we found increased expression of various members of the Wnt
signaling pathway in the synovium in two experimental OA mouse
models. In addition, we found that expression of WISP1, a key down-
stream target of the canonical Wnt signaling, was signiﬁcantly elevated
in the synovium and cartilage in experimental OAmodels and in human
OA cartilage. However, the role of WISP1 in the initiation and pro-
gression of OA is not known. In the present study, we investigated the
role ofWISP1 during OA by inducing various experimental OAmodels in
WISP1 KO mice. In addition, we determined if WISP1 was involved in
the progression of early OA in humans.
Methods: Pathway analysis of microarray data from the synovium of
both a collagenase-induced OA (CIOA) and a destabilization of the
medial meniscus (DMM) mouse model was performed using DAVID.
Microarray analysis was performed on the synovial tissue of patients
enrolled in the CHECK study. This cohort study is a multicenter based
initiative of the Dutch Arthritis Foundation to follow the progression of
OA symptoms in patients that visited their general practitioner with
early complaints of knee or hip pain. Expression data was correlated
with damage at baseline and progression of OA between baseline and
the ﬁve-year follow-up measurement. Progression was deﬁned as a
decrease in joint space width of at least 1 mm and progression of
osteophyte formation of at least 4x in size. Experimental OA was
induced in WT and WISP1 KO mice. Joint pathology was assessed by
histology. Human OA synovium was obtained after joint replacement
surgery and stimulated with WISP1. Smad phosphorylation and b-cat-
enin accumulation were determined using immunohistochemistry.
Results: Pathway analysis of microarray data from synovial tissue
showed enrichment of the Wnt signaling pathway in both the CIOA and
DMM at various time points after induction. In addition, microarray
analysis of synovial tissue obtained from patients in the CHECK cohort
of early OA patients showed a correlation between WISP1 expression
and damage at baseline. Moreover, WISP1 expression levels were cor-
related with the progression of OA between baseline and the ﬁve-year
follow-up measurement. In order to further pinpoint the role of WISP1
in the etiopathology of OA, we induced experimental OA in WT and
WISP1 KO mice. After the development of OA pathology, we found
signiﬁcantly decreased cartilage damage in the tibio-femoral joints of
theWISP1 KOmice as compared with theWTmice. Synovium ofWISP1
